Acquisition by Lubner David Charles of 9174 shares of Arcellx at 63.68 subject to Rule 16b-3
| ACLX Stock | USD 72.04 0.04 0.06% |
Slightly above 53% of Arcellx's investor base is interested to short. The analysis of overall sentiment of trading Arcellx stock suggests that many investors are impartial at this time. Arcellx's investing sentiment can be driven by a variety of factors including economic data, Arcellx's earnings reports, geopolitical events, and overall market trends.
Filed transaction by Arcellx Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Arcellx Fundamental Analysis
We analyze Arcellx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arcellx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arcellx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Arcellx is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Arcellx Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arcellx stock to make a market-neutral strategy. Peer analysis of Arcellx could also be used in its relative valuation, which is a method of valuing Arcellx by comparing valuation metrics with similar companies.
Peers
Arcellx Related Equities
| AMLX | Amylyx Pharmaceuticals | 2.76 | ||||
| DAWN | Day One | 2.08 | ||||
| NUVL | Nuvalent | 0.34 | ||||
| BMEA | Biomea Fusion | 1.86 | ||||
| VTYX | Ventyx Biosciences | 5.15 |
Additional Tools for Arcellx Stock Analysis
When running Arcellx's price analysis, check to measure Arcellx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcellx is operating at the current time. Most of Arcellx's value examination focuses on studying past and present price action to predict the probability of Arcellx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcellx's price. Additionally, you may evaluate how the addition of Arcellx to your portfolios can decrease your overall portfolio volatility.